Mohammad Almasri

7PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 30, 2026
Plasma metabolomics and ctDNA analysis in newly diagnosed diffuse large B-cell lymphoma: an exploratory study.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jul 08, 2025
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Riccardo Dondolin, Federico Garrou, Mohammad Almasri

|Jan 18, 2025
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Riccardo Moia, Donatella Talotta, Lodovico Terzi Di Bergamo

|Dec 17, 2024
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Jana Nabki, Bashar Al Deeban, Abel Mehari Sium

|Feb 25, 2022
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia.

Mohammad Almasri, Marah Amer, Joseph Ghanej

Pageof 2

Frequent Collaborators

7 joint publications

Gianluca Gaidano

6 joint publications

Riccardo Moia

5 joint publications

Chiara Cosentino

5 joint publications

Luca Cividini